Table 3.
The clinical manifestation and lesions size and the scores before treatment and 6-months follow-up after the last session
| No | Mean ± SD | |
|---|---|---|
| The clinical manifestation at baseline | Atrophy | 2.07±0.69 |
| Depig mentatior | 2.43±0.57 | |
| Hyperkertosis | 2.17±0.75 | |
| Lesions size at baseline | Sclerosis | 1.7±0.88 |
| <30% | 0.05±0.15 | |
| 30-60% | 0.27±0.45 | |
| >60% | 0.95±0.74 | |
| Total scores | 9.73±2.47 | |
| The clinical manifestation at last follow-up | Atrophy | 0.25±0.43 |
| Depigmentation | 0.47±0.57 | |
| Hyperkertosis | 0.17±0.38 | |
| Lesions size at last follow-up | Sclerosis | 0.17±0.35 |
| <30% | 0.25±0.25 | |
| 30-60% | 0±0 | |
| >60% | 0±0 | |
| Total scores | 1.23±1.65 |